Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
75°
Partly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
RxSight, Inc. - Common Stock
(NQ:
RXST
)
7.350
-0.030 (-0.41%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about RxSight, Inc. - Common Stock
< Previous
1
2
3
Next >
RXST Investors Have Opportunity to Join RxSight, Inc. Fraud Investigation with the Schall Law Firm
July 18, 2025
From
The Schall Law Firm
Via
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
July 18, 2025
From
Pomerantz LLP
Via
GlobeNewswire
RXST BREAKING NEWS: BFA Law is Investigating RxSight, Inc. for Securities Fraud; Contact the Firm about how to Potentially Recover Investment Losses
July 17, 2025
From
Bleichmar Fonti & Auld LLP
Via
Business Wire
Securities Fraud Investigation Into RxSight, Inc. (RXST) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
July 16, 2025
From
Glancy Prongay & Murray LLP
Via
Business Wire
RxSight, Inc. (RXST) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
July 16, 2025
From
Law Offices of Howard G. Smith
Via
Business Wire
RXSIGHT ALERT: Bragar Eagel & Squire, P.C.Announces Investigation into RxSight, Inc. (RXST) and Encourages Investors to Contact the Firm
July 15, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Robbins LLP is Investigating the Officers and Directors of RxSight, Inc. (RXST) to Determine if They Breached Fiduciary Duties Owed to Shareholders
July 15, 2025
From
Robbins LLP
Via
GlobeNewswire
Securities Fraud Investigation Into RxSight, Inc. (RXST) Continues – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
July 15, 2025
From
Law Offices of Frank R. Cruz
Via
Business Wire
Securities Fraud Investigation Into RxSight, Inc. (RXST) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
July 11, 2025
From
Glancy Prongay & Murray LLP
Via
Business Wire
RxSight, Inc. (RXST) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
July 11, 2025
From
Law Offices of Howard G. Smith
Via
Business Wire
Securities Fraud Investigation Into RxSight, Inc. (RXST) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
July 10, 2025
From
The Law Offices of Frank R. Cruz
Via
Business Wire
RxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Revised 2025 Guidance
July 08, 2025
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum
May 20, 2025
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. Reports First Quarter 2025 Financial Results
May 07, 2025
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Present at the Bank of America Healthcare Conference
April 30, 2025
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025
April 23, 2025
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance
April 02, 2025
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
March 25, 2025
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance
February 25, 2025
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025
February 11, 2025
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance
January 12, 2025
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
January 02, 2025
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. Reports Third Quarter 2024 Financial Results
November 07, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024
October 24, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences
August 22, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. Reports Second Quarter 2024 Financial Results
August 05, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024
July 22, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. To Participate in the Truist Securities Medtech Conference
June 05, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 13, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. Announces Pricing of Public Offering of Common Stock
May 08, 2024
From
RxSight, Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.